Burdette Medical Systems Overview
- Founded
-
1997
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Burdette Medical Systems General Information
Description
Developer of medical devices, systems, and software for guidance and visualization of minimally invasive treatments for cancer and other diseases. The company's inter plant II system transforms brachy therapy treatment for prostate cancer using real-time intra-operative treatment guidance and 3-D visualization. Its Dynamic-Dosimetry software allows viewing actual treatment dose as the implant progresses and making changes intra-operatively. The company's strategic partners include Johns Hopkins University and Medical School, Harvard Medical School, and Provena Health.
Contact Information
Website
www.burdettemedical.com
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Other Healthcare Technology Systems
Acquirer
Primary Office
- 2110 Clearlake Boulevard
- Suite 102
- Champaign, IL 61822
- United States
+1 (217) 000-0000
Burdette Medical Systems Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Burdette Medical Systems Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Clif Burdette Ph.D | President & CEO |